The other application CDx, so companion diagnostics could be really big for us in DKD clinical trials. There is a lot happening with that in Big Pharma & smaller Biotechs (DXB are using PromarkerD in current trials) & I do tend to keep on top of reading in this area, being invested in DXB also.
on a search of USA Gov trial site for DKD clinical trials, which lists international trials also, there were 450 clinical trials, with 64 currently recruiting & not yet recruiting clinical trials, this number doesn’t include CKD trials.
https://clinicaltrials.gov/ct2/results?recrs=ab&cond=Diabetic+Kidney+Disease&term=&cntry=&state=&city=&dist=
I think the simplicity of testing for trial sites & managing data for clinical trial sponsors, would be of big benefit in monitoring trial participants & response to trial drugs. Be interesting to see what happens in this space for ProMarkerD.
- Forums
- ASX - By Stock
- $30M EV and $248M US Annual Revenue Potential
PIQ
proteomics international laboratories ltd
Add to My Watchlist
0.00%
!
39.5¢

The other application CDx, so companion diagnostics could be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9722 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 44999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9722 | 0.380 |
1 | 1400 | 0.375 |
6 | 97160 | 0.370 |
1 | 10000 | 0.365 |
4 | 13174 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 44999 | 1 |
0.400 | 14573 | 2 |
0.410 | 100000 | 1 |
0.420 | 10000 | 1 |
0.430 | 20000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online